HAS updates its recommendations for the proper use of osteoporosis drugs

Haute Autorité de Santé

24 January 2023 - Osteoporosis is a disease whose first cause is ageing and which is characterised by the reduction of bone resistance, which increases the risk of fracture. 

Among the preventive measures, there are specific drug treatments. Their implementation must meet certain criteria in order to optimise their effectiveness. 

In order to guide health care professionals when initiating these treatments, HAS has updated the sheet on the proper use of osteoporosis medications.

Read HAS News

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Guidelines , France